Table 1 patient characteristics.

Number of patients

84

56

Sex: male

76 (90%)

51(91%)

Age (median, range)

43 (24 - 70)

41 (24 - 62)

Rise factor

Haemophilia

56 (67%)

35 (63%)

i. v. drugs

22 (26%)

16(29%)

man who have sex with man

6 (7%)

5 (9%)

HCV-RNA negative

14(17%)

5 (9%)

HCV viral load > 800000 1 U/1

55 (66%)

39 (70%)

HCV-Genotype

1

52 (62%)

39 (72%)

2

6(7%)

3 (6%)

3

13(16%)

10(19%)

4

4 (5%)

2 (4%)

HAART

67 (82%)

46 (84%)

PI-based HAART

50 (75%)

37 (80%)

NNRTI-based HAART

17 (25%)

9 (20%)

< 50 HIV copies/ml

62 (74%)

43 (77%)

CD4-Count (median, range) [cell/μl

397 (10 - 1757)

394 (10 - 966)

AST (median, range) [U/l]

47 (21 - 197)

48 (21 - 197)

ALT (median, range) [U/l]

72 (8 - 275)

77 (16 - 275)

Platelets (median, range) [T/l]

160 (9 - 337)

148 (9 - 325)

Stiffness (median, range) [kPa]

7.4 (3.3 - 48)

7.8 (3.3 - 48)

APRI (median, range)

n = 75

n = 52

0.9 (0.3 - 43.2)

11.1 (0.4 - 43.2)

FIB-4 (median, range)

n = 75

n = 52

11.6 (0.5 - 50.3)

11.6 (0.5 - 50.3)

IL28B genotype:

CC

42 (50%)

26 (46%)

CT

36 (43%)

25 (45%)

TT

6(7%)

5 (9%)

Time of follow-up (median, range) [months]

25 (5 - 50)